The Global Tranilast Market was valued at US$ 156 million in 2024 and is projected to reach US$ 203 million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period 2024–2030. This steady growth is being driven by rising demand for anti-allergic therapeutics, expanding research into fibrotic disorder treatments, and growing scientific interest in tranilast’s potential applications in oncology and beyond.

The United States Tranilast market alone was valued at US$ 42 million in 2024 and is projected to reach US$ 53 million by 2030, at a CAGR of 4.0% during the same forecast period, reflecting sustained clinical and commercial interest in this compound across North America.

Tranilast—an analog of a metabolite of tryptophan—has long been recognized for its anti-allergic properties, primarily in the treatment of asthma, atopic dermatitis, and fibrotic conditions. However, emerging research into its role in suppressing cancer cell proliferation and collagen synthesis is rapidly expanding its market relevance. As the pharmaceutical and chemical industries continue to explore new therapeutic applications, the spotlight turns to the companies at the forefront of tranilast manufacturing, supply, and research. In this blog, we profile the Top 10 Companies in the Global Tranilast Market—a mix of pharmaceutical manufacturers, life sciences suppliers, and specialty chemical firms shaping the future of this niche but growing sector.

Download FREE Sample Report:
Global Tranilast Market – View in Detailed Research Report

---

🔟 1. Daiwa Pharmaceutical Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Rizaben® (Tranilast), Anti-allergic Pharmaceutical Formulations

Daiwa Pharmaceutical is the original developer and pioneer of tranilast, having first introduced it to the Japanese pharmaceutical market under the brand name Rizaben®. The company has decades of expertise in the clinical application of tranilast for allergic rhinitis, bronchial asthma, atopic dermatitis, and keloid management. Daiwa’s foundational research on tranilast continues to influence the global scientific community and remains the benchmark for quality and efficacy in this space.

Key Strengths:

• Original innovator of tranilast with decades of clinical data

• Strong domestic market presence in Japan with established distribution networks

• Ongoing research into tranilast’s broader therapeutic applications

---

9️⃣ 2. Cayman Chemical Company

Headquarters: Ann Arbor, Michigan, USA
Key Offering: High-Purity Tranilast Research Compounds, Biochemical Reagents

Cayman Chemical is a globally respected supplier of biochemical tools and research-grade compounds, including high-purity tranilast for scientific and preclinical applications. The company serves pharmaceutical researchers, academic institutions, and biotechnology firms that require rigorously validated compounds for in vitro and in vivo studies. Cayman’s commitment to compound purity and comprehensive analytical documentation makes it a preferred partner for tranilast-related research worldwide.

Key Strengths:

• ISO-certified manufacturing with stringent quality controls

• Extensive catalog supporting early-stage pharmaceutical research

• Strong global distribution with rapid fulfillment capabilities

---

8️⃣ 3. MANUS AKTTEVA BIOPHARMA LLP

Headquarters: Ahmedabad, Gujarat, India
Key Offering: Tranilast API (Active Pharmaceutical Ingredient), Custom Synthesis

MANUS AKTTEVA BIOPHARMA is a leading Indian manufacturer of active pharmaceutical ingredients, including tranilast, with a robust focus on export markets across Asia, Europe, and North America. The company provides cost-competitive, high-quality tranilast API with full regulatory compliance, making it an important player in the global supply chain. Furthermore, its custom synthesis capabilities allow it to serve clients with specific purity and formulation requirements.

Key Strengths:

• Competitive API pricing backed by efficient manufacturing processes

• Regulatory filings supporting export to major global markets

• Flexible custom synthesis and contract manufacturing services

Download FREE Sample Report:
Global Tranilast Market – View in Detailed Research Report

---

7️⃣ 4. Enzo Life Sciences, Inc.

Headquarters: Farmingdale, New York, USA
Key Offering: Tranilast Research Reagents, Biochemistry and Life Science Tools

Enzo Life Sciences is a well-established provider of life science reagents and research tools, supplying tranilast as part of its broad biochemical catalog used in pharmacological and cellular research. The company’s tranilast products are widely used in studies exploring inflammation pathways, fibroblast inhibition, and anti-proliferative mechanisms. Enzo’s strength lies in combining high-quality compound supply with technical scientific support.

Key Strengths:

• Vertically integrated research reagent supply chain

• Strong portfolio supporting immunology and oncology research

• Globally recognized brand among academic and pharmaceutical researchers

---

6️⃣ 5. AOBIOUS Inc.

Headquarters: Gloucester, Massachusetts, USA
Key Offering: Tranilast (Research Grade), Specialty Biochemicals

AOBIOUS is a specialty biochemical supplier with a focused catalog of research compounds that includes tranilast at defined purity grades. The company primarily serves the life sciences research community, providing compounds that meet the rigorous standards required for pharmacological testing and drug discovery programs. AOBIOUS positions itself as a reliable, responsive supplier for laboratories seeking specialty compounds with fast turnaround and consistent quality.

Key Strengths:

• Focused catalog of high-value specialty research compounds

• Responsive customer service tailored to research laboratory needs

• Consistent purity and documentation supporting regulatory submissions

---

5️⃣ 6. Adooq Bioscience LLC

Headquarters: Irvine, California, USA
Key Offering: Tranilast Inhibitor Compounds, Drug Discovery Research Tools

Adooq Bioscience specializes in the development and supply of small molecule inhibitors and research compounds used in drug discovery and preclinical research. Their tranilast offerings are particularly relevant to research teams exploring TGF-β signaling inhibition, fibrosis, and cancer therapy. The company has built a strong reputation in the research community for its well-characterized compound libraries and precise quality standards.

Key Strengths:

• Specialized in small molecule inhibitors for drug discovery

• Strong emphasis on compound characterization and biological activity data

• Active support for oncology and fibrosis research programs

Download FREE Sample Report:
Global Tranilast Market – View in Detailed Research Report

---

4️⃣ 7. FUJIFILM Wako Pure Chemical Corporation

Headquarters: Osaka, Japan
Key Offering: Tranilast (High Purity 98%–99%), Pharmaceutical-Grade Chemicals

FUJIFILM Wako Pure Chemical Corporation is one of Japan’s most distinguished suppliers of high-purity chemicals for pharmaceutical, industrial, and research use. As part of the globally recognized FUJIFILM Holdings group, Wako provides tranilast at pharmaceutical-grade purity levels, making it a preferred supplier for Japanese and international formulation companies. The company’s rigorous quality management and extensive product documentation distinguish it in a competitive market.

Key Strengths:

• Part of FUJIFILM Holdings — a globally trusted brand in chemicals and diagnostics

• Pharmaceutical-grade purity with comprehensive quality certification

• Well-established supply infrastructure across Asia and beyond

---

3️⃣ 8. LGM Pharma

Headquarters: Nashville, Tennessee, USA
Key Offering: Tranilast API Sourcing, Pharmaceutical Development Support

LGM Pharma is a full-service API sourcing company that assists pharmaceutical manufacturers in locating, qualifying, and procuring active pharmaceutical ingredients including tranilast. With a strong network of global manufacturing partners and deep regulatory expertise, LGM Pharma bridges the gap between API producers and drug product developers. The company is particularly valued for its regulatory support capabilities, helping clients navigate FDA, EMA, and ICH requirements efficiently.

Key Strengths:

• Expertise in regulatory compliance and API qualification for global markets

• Broad sourcing network connecting manufacturers with reliable API suppliers

• Dedicated support for drug development from API procurement to NDA filing

---

2️⃣ 9. BioChemPartner

Headquarters: Shanghai, China
Key Offering: Tranilast Compounds, Custom Chemical Synthesis

BioChemPartner is a China-based pharmaceutical research services company offering a broad catalog of bioactive compounds and custom synthesis services, with tranilast among its commercially available compounds. The company serves global pharmaceutical and biotech clients looking for cost-effective research-grade and development-grade tranilast. BioChemPartner’s competitive pricing and solid quality standards have helped it establish a growing international client base, particularly among early-stage drug discovery programs.

Key Strengths:

• Cost-competitive pricing with reliable purity standards

• Custom synthesis capabilities for specialized research requirements

• Growing global presence in pharmaceutical outsourcing services

---

1️⃣ 10. CarboMer, Inc.

Headquarters: San Diego, California, USA
Key Offering: Tranilast Fine Chemicals, Specialty Pharmaceutical Ingredients

CarboMer is a specialty chemicals supplier serving the pharmaceutical, cosmetic, and life sciences industries with a diverse portfolio of fine chemicals that includes tranilast. The company prides itself on quality sourcing, competitive lead times, and customer-specific packaging and documentation. CarboMer’s ability to cater to both small-volume research needs and larger commercial procurement requirements makes it a versatile participant in the tranilast supply ecosystem.

Key Strengths:

• Versatile supply model accommodating research and commercial volumes

• Customer-centric documentation and packaging services

• Reliable sourcing network supporting consistent compound availability

Get Full Report Here:
Global Tranilast Market – View in Detailed Research Report

---

🌍 Outlook: The Future of the Tranilast Market Is Driven by Science and Innovation

The global tranilast market is entering a compelling phase of evolution. While its foundation remains rooted in anti-allergic and anti-fibrotic therapy, the expanding scientific evidence supporting tranilast’s role in cancer cell inhibition, TGF-β pathway suppression, and cardiovascular protection is opening entirely new commercial avenues. Because regulatory interest in fibrosis-related compounds is intensifying worldwide, tranilast is increasingly attracting attention from both established pharmaceutical companies and emerging biotech ventures.

📈 Key Trends Shaping the Market:

• Rising clinical research into tranilast’s efficacy in fibrotic and oncological indications

• Growing demand for high-purity (99%) tranilast in advanced pharmaceutical formulations

• Expansion of API manufacturing capabilities in Asia, particularly India and China

• Increasing investment in novel drug delivery systems to improve tranilast bioavailability

• Regulatory approvals and pipeline activity stimulating broader market participation

Get Full Report Here:
Global Tranilast Market – View in Detailed Research Report

The companies profiled above are not only supplying the global tranilast market—they’re actively shaping the scientific and commercial trajectory of this versatile therapeutic compound. From Japan’s founding innovator Daiwa Pharmaceutical to the research reagent leaders and API specialists spread across North America, Europe, and Asia, these organizations collectively represent the infrastructure upon which the next generation of tranilast-based therapies will be built.